ITGAM and chronic myelogenous leukemia, BCR-ABL1 positive: A median of 48% of CD11b cells from CML patients (n = 17) expressed PD-L1, this was significant different from the expression in control subjects (n = 21) where 23% of CD11b cells expressed PD-L1 (p<0,05).